147 related articles for article (PubMed ID: 10700164)
1. Axin and hepatocellular carcinomas.
Clevers H
Nat Genet; 2000 Mar; 24(3):206-8. PubMed ID: 10700164
[No Abstract] [Full Text] [Related]
2. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
3. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
[TBL] [Abstract][Full Text] [Related]
4. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
[TBL] [Abstract][Full Text] [Related]
5. New steps in the Wnt/beta-catenin signal transduction pathway.
Sakanaka C; Sun TQ; Williams LT
Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells.
Helmbrecht K; Kispert A; von Wasielewski R; Brabant G
Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224
[TBL] [Abstract][Full Text] [Related]
7. [beta-catenin].
Ogawa K; Yaginuma Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():161-6. PubMed ID: 11761935
[No Abstract] [Full Text] [Related]
8. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
Sakanaka C; Weiss JB; Williams LT
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
[TBL] [Abstract][Full Text] [Related]
9. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.
Liu C; Li Y; Semenov M; Han C; Baeg GH; Tan Y; Zhang Z; Lin X; He X
Cell; 2002 Mar; 108(6):837-47. PubMed ID: 11955436
[TBL] [Abstract][Full Text] [Related]
10. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
Kolligs FT; Hu G; Dang CV; Fearon ER
Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758
[TBL] [Abstract][Full Text] [Related]
11. Wnt/beta-catenin signaling.
Akiyama T
Cytokine Growth Factor Rev; 2000 Dec; 11(4):273-82. PubMed ID: 10959075
[TBL] [Abstract][Full Text] [Related]
12. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
[TBL] [Abstract][Full Text] [Related]
13. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability.
Shimizu Y; Ikeda S; Fujimori M; Kodama S; Nakahara M; Okajima M; Asahara T
Genes Chromosomes Cancer; 2002 Jan; 33(1):73-81. PubMed ID: 11746989
[TBL] [Abstract][Full Text] [Related]
14. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
Jho Eh; Lomvardas S; Costantini F
Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
[TBL] [Abstract][Full Text] [Related]
15. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
[TBL] [Abstract][Full Text] [Related]
16. [Genetic alterations in hepatocellular carcinomas: associations with clinical parameters].
Bluteau O; Laurent-Puig P; Zucman-Rossi J
Gastroenterol Clin Biol; 2001 Dec; 25(12):1067-77. PubMed ID: 11910987
[No Abstract] [Full Text] [Related]
17. Establishment of the dorso-ventral axis in Xenopus embryos is presaged by early asymmetries in beta-catenin that are modulated by the Wnt signaling pathway.
Larabell CA; Torres M; Rowning BA; Yost C; Miller JR; Wu M; Kimelman D; Moon RT
J Cell Biol; 1997 Mar; 136(5):1123-36. PubMed ID: 9060476
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 2A and its B56 regulatory subunit inhibit Wnt signaling in Xenopus.
Li X; Yost HJ; Virshup DM; Seeling JM
EMBO J; 2001 Aug; 20(15):4122-31. PubMed ID: 11483515
[TBL] [Abstract][Full Text] [Related]
19. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
Willert K; Shibamoto S; Nusse R
Genes Dev; 1999 Jul; 13(14):1768-73. PubMed ID: 10421629
[TBL] [Abstract][Full Text] [Related]
20. Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT - beta-catenin - TCF signaling pathway.
Terasaki H; Saitoh T; Shiokawa K; Katoh M
Int J Mol Med; 2002 Feb; 9(2):107-12. PubMed ID: 11786918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]